Psychedelic Decrim Efforts Advance in Three Cities Across the US

August 12, 2021 12:50:33

Psychedelic reform advocates in various states across the country are actively working to change laws that govern psychedelics, including ayahuasca and psilocybin. As part of those efforts, cities such as Arcata, California; Grand Rapids, Michigan; and Easthampton, Massachusetts, are the latest to climb aboard this reform train.

Thus far, the Public Safety Committee in the city of Arcata has advanced a psychedelics reform measure that was led by the Decriminalize Nature chapter in the city. This measure will allow the decriminalization of entheogens, which had been denied by the Arcata City Council, to be voted on again. The passage of this measure would deprioritize enforcement of the laws governing the possession and use of entheogens in private spaces and allow for an educational campaign on the issue to be established.

In Grand Rapids, City Commissioner Kurt Reppart, who is  playing the role of advisor to the city’s Decriminalize Nature chapter, recently revealed that he felt there was enough support to advance a psychedelics decriminalization measure. The local legislator stated in a recent interview that most of his colleagues had shown interest in the matter, with some expressing their explicit support for the initiative.

He added that the initiative could be voted on by the year’s end, noting that at the moment, the proposed language was being reviewed by the city attorneys, after which the measure would be advanced to the city’s Legislative Committee. Similar to most Decriminalize Nature resolutions, this particular one would not legalize psychedelics but deprioritize the enforcement of laws governing cultivation and simple possession offenses.

If the measure is approved, Grand Rapids would become the second city in the state of Michigan to pass a psychedelics decriminalization measure, following a unanimous vote by the City Council of Ann Arbor to approve a similar measure in 2020.

In Easthampton, the city council is debating a measure to decriminalize various entheogenic substances. The measure’s approval would make Easthampton the fourth city in the state to do so. The measure is being sponsored by Councilors Thomas Peake, Salem Derby and Owen Zaret, and it would make law enforcement against a wide range of psychedelics one of the lowest priorities of the city.

In a press release, Zaret stated that this was an opportunity to undo the harm done by the criminalization of these substances, which possess therapeutic properties, adding that individuals shouldn’t be incarcerated or arrested for basically using medicine. The measure is also being supported by LEAP. Other cities in the state of Massachusetts that have enacted this change in policy include Cambridge, Somerville and Northampton.

These decriminalization efforts make it even more urgent for companies such as Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to complete their psychedelic drug-development programs so that people can access approved psychedelic medicines instead of using products sold by black market operators.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.